Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - TOTAL CURRENT LIABILITIES
Total Current Liabilities KROS - Keros Therapeutics, Inc.
24.4 M
LAST VALUE
43.44%
2 YEAR CAGR
16.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR